Evommune, Inc. (EVMN) has 5 SEC Form 4 insider filings on record in the last 90 days. That includes 2 insider purchases totalling $146K, and 1 sales totalling $169K. Most recent filing: July 10, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| July 10, 2026 filed July 8, 2026 | Carver Kyle Chief Financial Officer | +$13,260 | 1,000 | +2% | No | |
|
|
||||||
| July 8, 2026 filed July 7, 2026 | KIRSCH ARTHUR S Director | +$133,000 | 10,000 | New | No | |
|
|
||||||
| June 24, 2026 filed June 22, 2026 | Drew Janice Suzann Chief of Dev. Operations | $375,800 | 60,000 | 0% | Yes | |
|
|
||||||
| June 24, 2026 filed June 22, 2026 | Patel Jeegar Pravinkumar Chief Scientific Officer | $27,766 | 4,464 | 0% | Yes | |
|
|
||||||
| June 24, 2026 filed June 22, 2026 | Pena Luis C. President & CEO | −$168,917 | 7,438 | −1% | Yes | |
|
|
||||||
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free